1 Ocak 2014 Dergi makalesi Açık Erişim

Sozmen, Mahmut; Devrim, Alparslan Kadir; Tunca, Recai; Bayezit, Murat; Dag, Serpil; Essiz, Dinc

JSON-LD (schema.org)

{
  "@context": "https://schema.org/", 
  "@id": 63215, 
  "@type": "ScholarlyArticle", 
  "creator": [
    {
      "@type": "Person", 
      "name": "Sozmen, Mahmut"
    }, 
    {
      "@type": "Person", 
      "affiliation": "Univ Mehmet Akif Ersoy, Fac Vet Med, Dept Biochem, TR-15100 Burdur, Turkey", 
      "name": "Devrim, Alparslan Kadir"
    }, 
    {
      "@type": "Person", 
      "affiliation": "Adnan Menderes Univ, Fac Vet Med, Dept Pathol, TR-09010 Aydin, Turkey", 
      "name": "Tunca, Recai"
    }, 
    {
      "@type": "Person", 
      "affiliation": "Univ Mehmet Akif Ersoy, Fac Vet Med, Dept Pharmacol & Toxicol, TR-15100 Burdur, Turkey", 
      "name": "Bayezit, Murat"
    }, 
    {
      "@type": "Person", 
      "affiliation": "Kafkas Univ, Fac Vet Med, Dept Pathol, TR-36100 Kars, Turkey", 
      "name": "Dag, Serpil"
    }, 
    {
      "@type": "Person", 
      "affiliation": "Kirikkale Univ, Fac Vet Med, Dept Pharmacol & Toxicol, TR-71450 Kirikkale, Turkey", 
      "name": "Essiz, Dinc"
    }
  ], 
  "datePublished": "2014-01-01", 
  "description": "The present study was conducted to investigate the effect of silymarin on experimental liver toxication induced by Fumonisin B-1 (FB1) in BALB/c mice. The mice were divided into six groups (n = 15). Group 1 served as the control. Group 2 was the silymarin control (100 mg/kg by gavage). Groups 3 and 4 were treated with FB1 (Group 3, 1.5 mg/kg FB1, intraperitoneally; and Group 4, 4.5 mg/kg FB1). Group 5 received FB1 (1.5 mg/kg) and silymarin (100 mg/kg), and Group 6 was given a higher dose of FB1 (4.5 mg/kg FB1) with silymarin (100 mg/kg). Silymarin treatment significantly decreased (p < 0.0001) the apoptotic rate. FB1 administration significantly increased (p < 0.0001) proliferating cell nuclear antigen and Ki-67 expression. Furthermore, FB1 elevated the levels of caspase-8 and tumor necrosis factor-alpha mediators while silymarin significantly reduced (p < 0.0001) the expression of these factors. Vascular endothelial growth factor (VEGF) and fibroblast growth factor-2 (FGF-2) expressions were significantly elevated in Group 4 (p < 0.0001). Silymarin administration alleviated increased VEGF and FGF-2 expression levels (p < 0.0001). In conclusion, silymarin ameliorated toxic liver damage caused by FB1 in BALB/c mice.", 
  "headline": "Protective effects of silymarin on fumonisin B-1-induced hepatotoxicity in mice", 
  "identifier": 63215, 
  "image": "https://aperta.ulakbim.gov.tr/static/img/logo/aperta_logo_with_icon.svg", 
  "license": "http://www.opendefinition.org/licenses/cc-by", 
  "name": "Protective effects of silymarin on fumonisin B-1-induced hepatotoxicity in mice", 
  "url": "https://aperta.ulakbim.gov.tr/record/63215"
}